Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ocular tolerability of voclosporin ophthalmic solution to Restasis in dry eye disease; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Restasis (Cyclosporine A)
  • voclosporin ophthalmic solution (voclosporin)

Snippet

Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2021-07-08